Shishkova N, Kuznetsova O, Berezov T
Department of Biochemistry, School of Medicine, People's Friendship University of Russia, Miklukho-Maklay, 8, 117198, Moscow, Russia.
J Gastrointest Cancer. 2013 Sep;44(3):251-9. doi: 10.1007/s12029-013-9496-4.
Photodynamic therapy (PDT) is a minimally invasive and promising new modality to combat cancer. Upon illumination and in the presence of oxygen, the tissue-localized nontoxic sensitizer generates cytotoxic reactive oxygen species, and as a result, the selective destruction of a targeted tumor may be achieved. The major advantages of PDT compared to traditional standard of care for cancer treatment are higher selectivity and lower toxicity. The high degree of selectivity offered by this modality has been applied to cancer diagnosis by fluorescence.
This article is a review the clinical effectiveness of PDT in the treatment of Barrett's esophagus and the following cancers: esophageal, gastric, biliary tract, pancreatic, and colon. This review highlights the clinical responses to PDT and discusses the possibility of enhancing the efficacy of treatment by combination with targeted therapy.
光动力疗法(PDT)是一种用于对抗癌症的微创且有前景的新方法。在光照及有氧气存在的情况下,组织定位的无毒敏化剂会产生活细胞毒性的活性氧,从而可实现对靶向肿瘤的选择性破坏。与癌症治疗的传统标准护理相比,光动力疗法的主要优势在于更高的选择性和更低的毒性。这种方法所提供的高度选择性已被应用于荧光癌症诊断。
本文综述了光动力疗法在治疗巴雷特食管及以下癌症(食管癌、胃癌、胆管癌、胰腺癌和结肠癌)方面的临床疗效。本综述重点介绍了对光动力疗法的临床反应,并讨论了通过与靶向治疗联合来提高治疗效果的可能性。